basilar migraine


Also found in: Dictionary, Thesaurus, Encyclopedia.

bas·i·lar mi·graine

a migraine accompanied by transient brainstem signs (for example, vertigo, tinnitus, perioral numbness, diplopia) thought to be due to vasospastic narrowing of the basilar artery.

basilar migraine

A type of classical migraine often associated with the menstrual cycle that first appears in adolescence and occurs primarily in young women, which is linked to a vasomotor defect of the carotid or vertebrobasilar arteries; in basilar migraines, aura symptoms are thought to arise in the brainstem or occipital lobes.
 
Clinical findings
Loss of consciousness, drop attacks, vertigo, alternating hemiplegia and confusion; may be accompanied by ataxi, incoordination, diplopia, dysarthria and nystagmus, as well as pallor, vomiting and photophobia; possibly followed by polydipsia, polyuria and irritability.

basilar migraine

Neurology A type of classical migraine that first appears in adolescence, primarily in young ♀, often associated with the menstrual cycle, which is linked to a vasomotor defect of a major brain artery (carotid, vertebrobasilar); in BMs, aura symptoms are thought to arise in the brainstem or occipital lobes Clinical Loss of consciousness, drop attacks, vertigo, alternating hemiplegia, and confusion, +– accompanied by ataxia, incoordination, diplopia, dysarthria, and nystagmus, as well as pallor, vomiting, and photophobia, possibly followed by polydipsia, polyuria, irritability. See Classical migraine.

bas·i·lar mi·graine

(basi-lăr mīgrān)
Headache accompanied by transient brainstem signs (e.g., vertigo, tinnitus, perioral numbness, diplopia).

bas·i·lar mi·graine

(basi-lăr mīgrān)
Migraine accompanied by transient brainstem signs (e.g., vertigo, tinnitus, perioral numbness, diplopia) thought due to vasospastic narrowing of basilar artery.
References in periodicals archive ?
Lewis recommends the "start low, go slow" approach to topiramate titration for basilar migraine in children.
The drug also significantly reduced the number of days with basilar migraines in each group from a median of 3 days to a median of 0.
Migranal also should not be given to patients with uncontrolled hypertension, patients who have used 5-HT1 agonists, ergotamine-containing or ergot-type medications or methysergide within the last 24 hours, or patients with hemiplegic or basilar migraine.
MIGRANAL Nasal Spray also should not be given to patients with uncontrolled hypertension, patients who have used 5-HT(1) agonists, ergotamine-containing or ergot-type medications or methysergide within the last 24 hours, or patients with hemiplegic or basilar migraine.